Market News (Page 38) - TendieTensor

Market News Page 38 of 291 • 7,269 articles

Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA

Benzinga • Prnewswire

Charming Medical Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MCTA

01/05/2026 02:46 PM • The DJS Law Group announced a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for securities law violations. The SEC suspended trading of MCTA shares following an investigation into an alleged scheme to artificially boost the company's share price through social media promotion by financial advisors. The class period covers October 21, 2025 to November 12, 2025, with a deadline of February 17, 2026 for shareholders to join the lawsuit.

INOD - Provides critical AI data preparation services for major tech companies, with expected revenue and earnings growth of 22% and 13% CAGR from 2024 to 2027
MCTA - The company faces a class action lawsuit for securities violations, SEC trading suspension, and allegations of fraudulent share price manipulation through coordinated social media promotion. These serious regulatory and legal issues pose significant risks to shareholders and the company's reputation.

#securities law violations #class action lawsuit #SEC investigation #share price manipulation #trading suspension #investor losses

smart Expands Global Reach in 2025, Set to Open New Frontiers in 2026

GlobeNewswire Inc. • Globe Newswire

smart Expands Global Reach in 2025, Set to Open New Frontiers in 2026

01/05/2026 02:00 PM • Premium EV brand smart expanded to 39 markets in 2025 by launching in 10 new countries and growing its retail network by 25% to 688 outlets. The company plans to introduce two new models (#2 and #6) in 2026 while strengthening customer services through AI-enhanced smartcare. All smart models have earned Red Dot Design Awards and 5-Star Euro NCAP Safety Ratings.

GELHY - As co-founder of the smart joint venture with Mercedes-Benz, Geely benefits from the brand's expansion to 39 markets, 25% retail network growth, and strong product recognition. The company's investment in smart is yielding positive returns through market penetration and operational success.

#electric vehicles #global expansion #market launch #premium automotive #product roadmap #retail network growth #customer services #design awards #safety ratings

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Perrigo Company plc (PRGO) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

01/05/2026 01:49 PM • Glancy Prongay & Murray LLP is alerting Perrigo Company plc investors about a securities fraud class action lawsuit with a January 16, 2026 deadline to file as lead plaintiff. The lawsuit alleges that Perrigo made materially false statements regarding its acquisition of Nestlé's infant formula business, failing to disclose significant underinvestment, manufacturing deficiencies, and the need for substantial remediation costs exceeding initial estimates. The company's stock fell significantly on multiple occasions (15.14%, 9.8%, 11.31%, and 25.2%) as it repeatedly revised guidance downward due to infant formula business challenges.

PRGO - The company is the subject of a securities fraud lawsuit alleging material misstatements and omissions regarding its infant formula business acquisition. Multiple significant stock price declines (totaling over 60% from peak to trough during the class period), repeated downward guidance revisions, and undisclosed manufacturing and operational issues indicate serious business and legal challenges.

#securities fraud #class action lawsuit #infant formula business #Nestlé acquisition #misstatements #manufacturing deficiencies #remediation costs #guidance revision #stock decline

Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. • Glancy Prongay & Murray Llp

Deadline Alert: Alexandria Real Estate Equities, Inc. (ARE) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

01/05/2026 01:45 PM • Alexandria Real Estate Equities (ARE) faces a securities fraud class action lawsuit after missing Q3 2025 earnings estimates and cutting full-year guidance. The company disclosed a $323.9 million real estate impairment charge, with $206 million attributed to its Long Island City property. The stock fell 19.2% on the news. Investors have until January 26, 2026 to file a lead plaintiff motion, with allegations that the company misrepresented the value and occupancy prospects of its LIC property.

ARE - The company missed Q3 earnings estimates, cut full-year FFO guidance, disclosed a $323.9 million impairment charge, and faces a securities fraud lawsuit alleging material misstatements about its Long Island City property's value and occupancy. Stock declined 19.2% on the announcement.

#securities fraud #class action lawsuit #earnings miss #impairment charge #Long Island City #occupancy decline #stock price decline

Bioanalytical Services Market Projected to Reach US$ 11.61 Billion by 2035, Driven by Rising FDA Approvals and Clinical Trial Activity Says Astute Analytica

GlobeNewswire Inc. • Astute Analytica

Bioanalytical Services Market Projected to Reach US$ 11.61 Billion by 2035, Driven by Rising FDA Approvals and Clinical Trial Activity Says Astute Analytica

01/05/2026 01:00 PM • The global bioanalytical services market is expected to grow from US$ 3.96 billion in 2025 to US$ 11.61 billion by 2035 at a CAGR of 11.6%. Growth is driven by FDA Modernization Act 2.0 implementation, increased clinical trial activity, and a shift toward advanced testing methodologies like cell-based assays and LC-MS/MS platforms. Cell-based assays lead with 46.1% market share, while small molecules account for 55.4%. Oncology applications dominate at 32% share, driven by the explosive pipeline of 1,200+ Antibody-Drug Conjugates.

LH - Expanded Singapore bioanalytical facility to 7,300 square meters with 90 new high-skilled roles, strengthening Asia-Pacific presence

#bioanalytical services #FDA Modernization Act 2.0 #cell-based assays #LC-MS/MS #clinical trials #oncology #antibody-drug conjugates #small molecules #bioequivalence testing #contract research organizations

Yamaha Motor Corp, USA, Promotes Dean Burnett to Senior Vice President and President of Motorsports Division

GlobeNewswire Inc. • Yamaha Motor Corporation, U.S.A.

Yamaha Motor Corp, USA, Promotes Dean Burnett to Senior Vice President and President of Motorsports Division

01/05/2026 01:00 PM • Yamaha Motor Corp., USA promotes Dean Burnett to Senior Vice President and President of Motorsports, replacing retiring Mike Martinez after 32 years. Burnett brings over three decades of Yamaha experience across marine, finance, and Canadian operations. Martinez will transition through Q1 2026, officially retiring April 3, 2026.

SNPS - Mentioned briefly with no specific details about performance or legal issues
YMHAY - The promotion of an experienced internal candidate with 39 years of Yamaha experience demonstrates strong succession planning and organizational stability. The smooth transition plan with overlap period and CEO confidence in the new leader indicates effective management continuity and reduces execution risk.

#executive promotion #leadership transition #motorsports division #retirement #succession planning #Yamaha Motor

Stock Of The Day: Is The Chevron Rally About To End?

Benzinga • Mark Putrino

Stock Of The Day: Is The Chevron Rally About To End?

01/05/2026 12:58 PM • Chevron (CVX) shares are trading higher on Monday following optimism about the company's future prospects in Venezuela after President Nicolás Maduro's removal from office. However, technical analysis suggests the rally may be short-lived, with potential resistance forming around $169 due to buyer's remorse from investors who purchased at that level in April.

BYND - Mentioned briefly in a separate stock alert with no specific details provided in the main article.
CVX - While the stock is rallying on positive Venezuela news, technical analysis suggests the rally may be short-lived with resistance expected around $169. The article presents both bullish momentum and bearish technical headwinds, resulting in a neutral outlook.

#Chevron #CVX #technical analysis #Venezuela #resistance level #stock rally #oil and gas

These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever

Investing.com • Dan Schmidt

These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever

01/05/2026 12:35 PM • With the S&P 500 trading at elevated valuations (26x forward earnings vs. 20-year average of 16x), the article identifies three undervalued stocks poised for potential gains: Comcast (trading at 6.84x P/E with strong broadband margins and upcoming sports broadcasting rights), Micron Technology (29x earnings with 57% revenue growth despite tech sector trading at 75x), and Pfizer (8.4x forward earnings with expanding GLP-1 pipeline and oncology growth from Seagen acquisition).

SNPS - Mentioned briefly in a separate stock alert with no specific details provided in the main article.
CCZ - Trading at 6.84x forward P/E (well below industry average of 16.5), strong broadband margins (37-56% EBITDA), $4.9B free cash flow, 4.4% dividend, and upcoming high-profile sports broadcasting rights (Super Bowl, World Cup, Olympics) expected to boost advertising revenue in 2026. Stock up 10% in last 30 days with bullish technical signals.

#undervalued stocks #value investing #S&P 500 valuations #cord-cutting #AI industry #semiconductor demand #GLP-1 drugs #portfolio diversification

Intel Builds Momentum as Panther Lake Raises Stakes for the 18A Turnaround

Investing.com • Timothy Fries

Intel Builds Momentum as Panther Lake Raises Stakes for the 18A Turnaround

01/05/2026 12:32 PM • Intel experiences significant momentum ahead of its Panther Lake processor launch at CES on January 5, 2026, with the stock rallying 6.7% on Friday. The Core Ultra Series 3 chips represent the first mass-production run of Intel's advanced 18A manufacturing process featuring gate-all-around transistors and backside power delivery technology. Nvidia's $5 billion strategic investment giving it 4% ownership in Intel has bolstered the rally, while the company aims to compete with TSMC and Samsung in the semiconductor market.

INTC - Strong 6.7% rally on Friday, approaching $42 psychological level, upcoming Panther Lake launch with advanced 18A process, strategic $5B investment from Nvidia, and positive momentum heading into CES presentation signal confidence in the company's turnaround efforts and competitive positioning.

#Panther Lake #18A manufacturing process #Core Ultra Series 3 #CES 2026 #semiconductor #foundry business #gate-all-around transistors

Bronstein, Gewirtz & Grossman LLC Urges Coupang, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Coupang, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/05/2026 12:00 PM • A class action lawsuit has been filed against Coupang, Inc. alleging that the company made false and misleading statements regarding inadequate cybersecurity protocols that allowed a former employee to access sensitive customer information for nearly six months. The lawsuit claims defendants failed to properly report the data breach to the SEC in compliance with applicable rules, causing investor damages when the true details became public. The class period covers purchases between August 6, 2025 and December 16, 2025.

CPNG - The company is accused of inadequate cybersecurity protocols, failure to detect unauthorized data access for six months, and non-compliance with SEC reporting requirements regarding the breach. These allegations of mismanagement and regulatory violations resulted in investor losses.

#class action lawsuit #securities fraud #data breach #cybersecurity #SEC reporting violations #investor damages #false statements

NXP’s New S32N7 Unlocks the Full Potential of SDVs

GlobeNewswire Inc. • Nxp Semiconductors

NXP’s New S32N7 Unlocks the Full Potential of SDVs

01/05/2026 12:00 PM • NXP Semiconductors unveiled the S32N7 super-integration processor series designed to centralize core vehicle functions across propulsion, dynamics, body, gateway, and safety domains. The processor enables automakers to reduce total cost of ownership by up to 20% through hardware consolidation and unlock AI-powered innovation. Bosch is the first to deploy the S32N7 in its vehicle integration platform, with the S32N79 variant currently sampling to customers.

SNPS - Briefly mentioned with no specific details about performance or legal issues
NXPI - NXP announced a significant technological advancement with the S32N7 processor series that addresses major industry needs for vehicle centralization and cost reduction. The product is already being adopted by major tier-1 supplier Bosch, demonstrating market validation and strong commercial potential. The innovation positions NXP favorably in the growing software-defined vehicle market.

#S32N7 processor #vehicle centralization #software-defined vehicles #automotive semiconductors #AI integration #cost reduction #vehicle architecture #hardware consolidation

Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

GlobeNewswire Inc. • Bronstein, Gewirtz & Grossman Llc

Bronstein, Gewirtz & Grossman LLC Urges Inspire Medical Systems, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

01/05/2026 12:00 PM • A class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) alleging that the company made materially false and misleading statements regarding market demand for Inspire V and its readiness for product launch. The lawsuit covers investors who purchased securities between August 6, 2024 and August 4, 2025. The law firm is seeking to recover damages for alleged violations of federal securities laws.

BYND - Briefly mentioned with no specific details about performance or legal issues
INSP - The company is the defendant in a securities fraud class action lawsuit alleging materially false and misleading statements about product demand and launch readiness, which resulted in investor losses and potential significant financial liability.

#class action lawsuit #securities fraud #Inspire V #market demand #product launch #investor harm #federal securities laws

These 3 Turnaround Contenders Could Be Set for a Big 2026 Break

Investing.com • Nathan Reiff

These 3 Turnaround Contenders Could Be Set for a Big 2026 Break

01/05/2026 11:37 AM • Three companies are positioned for potential breakout years in 2026: Royal Caribbean Cruises benefits from strong cruise bookings and consumer spending recovery; Take-Two Interactive is poised for growth driven by the highly anticipated Grand Theft Auto VI release in November 2026; and Airbnb is expanding into bundled services despite regulatory challenges and a weak 2025 performance.

BYND - Mentioned briefly with no specific details about performance or legal issues
RCL - Strong booking growth at high end of historical ranges, 275% share growth over 5 years, boosted 2025 EPS guidance by ~33% YOY, reinstated dividend with 1.44% yield, and 20 analysts optimistic with ~15% upside potential.

#turnaround stocks #2026 outlook #cruise industry recovery #video game releases #travel and lodging #consumer spending #earnings growth

Biometrics as a Service Market is expected to generate a revenue of USD 12,245.22 Million by 2032, Globally, at 26.13% CAGR: Verified Market Research®

GlobeNewswire Inc. • Verified Market Research

Biometrics as a Service Market is expected to generate a revenue of USD 12,245.22 Million by 2032, Globally, at 26.13% CAGR: Verified Market Research®

01/05/2026 11:00 AM • The global Biometrics as a Service market is projected to grow from USD 3.04 billion in 2024 to USD 12.25 billion by 2032, driven by rapid digital transformation, cloud adoption, and increasing deployment across BFSI, government, and healthcare sectors. However, data privacy concerns, integration complexities, and regulatory compliance challenges remain significant restraints to market expansion.

CINF - 65-year streak of dividend increases, stable insurance business model, ability to adapt to economic changes and inflation
LDOS - Key competitor positioned to benefit from government identity programs and border security investments driving biometric adoption.

#biometrics as a service #digital authentication #cloud-based security #identity verification #market growth #CAGR 26.13% #data privacy #regulatory compliance #BFSI sector #government identity programs

Specialty Silica Market Size to Reach USD 11.79 Billion by 2033 Due to the Increasing Demand from Automotive and Tire Industry for Fuel Efficiency | SNS Insider

GlobeNewswire Inc. • Sns Insider

Specialty Silica Market Size to Reach USD 11.79 Billion by 2033 Due to the Increasing Demand from Automotive and Tire Industry for Fuel Efficiency | SNS Insider

01/05/2026 11:00 AM • The global specialty silica market is projected to grow from USD 7.15 billion in 2025 to USD 11.79 billion by 2033, with a CAGR of 6.47%. Growth is driven by increasing demand from the automotive and tire industries for fuel efficiency, particularly in electric vehicle tires, and expanding applications in pharmaceuticals, food processing, and personal care. Precipitated silica leads the market with 40.16% share, while the U.S. market is expected to reach USD 2.30 billion by 2033.

CBT - Launched new hydrophobic fumed silica grade targeting the pharmaceutical sector in April 2024, showing active product innovation and expansion into high-growth pharmaceutical applications.

#specialty silica #automotive industry #tire manufacturing #electric vehicles #reinforcing filler #fuel efficiency #precipitated silica #silica gel #pharmaceuticals #market growth

North America's Helicopters Market to Witness 6.89% CAGR During 2025-2033: Analysis of Investment Opportunities, Competitive Strategies and Industry Developments

GlobeNewswire Inc. • Researchandmarkets.Com

North America's Helicopters Market to Witness 6.89% CAGR During 2025-2033: Analysis of Investment Opportunities, Competitive Strategies and Industry Developments

01/05/2026 11:00 AM • North America's helicopters market is projected to grow from $18.53 billion in 2024 to $33.75 billion by 2033, driven by increased demand for emergency medical services, military modernization programs, and offshore operations. However, high operating costs and stringent regulatory standards pose significant challenges to market expansion.

LUKOY - Company facing asset sale restrictions but granted limited negotiation window for potential foreign asset divestment
EADSY - Airbus is highlighted as a key player securing significant contracts, including a $27.8 million U.S. Army modernization contract and being selected by Global Medical Response for new air medical transport helicopters, demonstrating strong market positioning and growth opportunities.

#helicopters market #North America #emergency medical services #military modernization #offshore operations #market growth #CAGR #regulatory standards

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit with the Schall Law Firm

01/05/2026 11:00 AM • The Schall Law Firm is seeking investors to join a class action lawsuit against Perrigo Company plc for securities fraud. The lawsuit alleges that Perrigo made false and misleading statements regarding the baby formula business acquired from Nestlé, which suffered from serious underinvestment and required larger expenditures than disclosed to investors. The class period covers February 27, 2025 to November 4, 2025.

PRGO - The company is accused of making false and misleading statements to investors regarding the financial condition and investment requirements of its acquired baby formula business from Nestlé. The allegations indicate material misrepresentation that caused investor losses, resulting in a securities fraud lawsuit.

#securities fraud #class action lawsuit #Perrigo Company plc #baby formula business #Nestlé acquisition #investor losses #misleading statements

HCFO-1233zd Market Projected to Reach US$ 71.34 Million by 2035 | Astute Analytica

GlobeNewswire Inc. • Astute Analytica

HCFO-1233zd Market Projected to Reach US$ 71.34 Million by 2035 | Astute Analytica

01/05/2026 11:00 AM • The global HCFO-1233zd market is experiencing rapid growth driven by regulatory mandates phasing out high-GWP refrigerants and blowing agents. The market is projected to grow from $38.18 million in 2025 to $71.34 million by 2035 at a 6.4% CAGR. North America leads with 37% market share, while insulation foam blowing agents represent the largest application segment at 51.1%. Major producers are expanding capacity to meet surging demand from construction, data centers, and industrial heat pump applications.

ARKAY - Arkema executed a $60 million investment to launch a 15 kt/year HCFO-1233zd production facility in Kentucky in August 2025, demonstrating aggressive capacity expansion to capitalize on regulatory-driven market growth. The company is well-positioned to serve the booming polyurethane foam sector.

#HCFO-1233zd #low-GWP refrigerant #foam blowing agent #regulatory compliance #Kigali Amendment #industrial decarbonization #thermal management #capacity expansion

Solar Stocks Face a New Test as 2026 Begins With Momentum Still Intact

Investing.com • Ryan Hasson

Solar Stocks Face a New Test as 2026 Begins With Momentum Still Intact

01/05/2026 10:49 AM • Solar stocks delivered impressive gains in 2025, with the Invesco Solar ETF surging 48% despite initial policy uncertainty. As the sector enters 2026 with improved sentiment and clearer policy visibility, NextPower and First Solar are highlighted as two leading companies positioned to capitalize on continued momentum, though key technical support levels will be critical to watch.

O - 5.5% dividend yield, 28-year history of dividend raises, resilient business model with triple-net lease agreements, and built-in inflation protection
NXT - Stock surged 138% in 2025, analyst price targets raised from $53 to $95.76, consensus Moderate Buy rating, strong institutional inflows of $2.27B, beat earnings expectations by 21 cents, positive technical momentum with support at $84 holding potential for breakout above $90.

#solar stocks #renewable energy #2026 outlook #policy clarity #sector momentum #technical analysis #utility-scale projects

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Benzinga • Globe Newswire

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

01/05/2026 10:46 AM • Inspira Technologies Oxy (NASDAQ: IINN) announced a non-binding term sheet for acquiring an advanced liquid biopsy diagnostics business and receiving a $15 million strategic equity investment at a $180 million pre-money valuation. The acquisition includes an AI-powered platform for isolating and characterizing circulating tumor cells from blood samples, with initial focus on breast cancer. The company plans to pursue FDA 510(k) clearance and has structured the deal to protect existing shareholders' economic interests in its respiratory and blood monitoring technologies through contingent value rights.

IINN - The company is expanding into a high-growth liquid biopsy market ($58 billion projected over a decade) with a $15 million strategic investment at a significant premium to current market cap. The acquisition provides a development-ready platform with clear FDA regulatory pathway and existing reimbursement codes, while the shareholder protection framework preserves value from existing technologies. These factors represent substantial growth opportunities and strategic validation.

#liquid biopsy #cancer diagnostics #acquisition #equity investment #FDA clearance #circulating tumor cells #medical device #strategic investment

Oracle: A Hard Pass—or a Hard-to-Pass Opportunity?

Investing.com • Thomas Hughes

Oracle: A Hard Pass—or a Hard-to-Pass Opportunity?

01/05/2026 10:43 AM • Despite a 2025 stock price correction, Oracle presents a compelling long-term investment opportunity driven by its AI infrastructure strategy and dominant position in the global datacenter ecosystem. With 150 operating datacenters and 64 under construction (43% capacity increase), strong multicloud operations, and forecast 17% growth in 2026 followed by doubling in size by 2028, analysts maintain a Moderate Buy sentiment with 60% upside potential from critical support levels.

ORCL - Despite 2025 price correction, Oracle demonstrates strong fundamentals with 43% datacenter capacity expansion, 438% increase in Q2 FY2026 RPO indicating full booking, strategic positioning in AI/multicloud ecosystem, forecast 17% growth in 2026 and doubling by 2028, and analyst consensus showing 60% upside potential with bullish revision trend and Moderate Buy rating.

#AI infrastructure #datacenters #hyperscalers #multicloud operations #GPU #cloud regions #remaining performance obligations #analyst price targets #market correction

Why a 39% Portfolio Bet on CyberArk Signals Confidence in a $1.3 Billion ARR Engine

The Motley Fool • Jonathan Ponciano

Why a 39% Portfolio Bet on CyberArk Signals Confidence in a $1.3 Billion ARR Engine

01/05/2026 10:30 AM • London-based Samson Rock Capital increased its stake in CyberArk Software to 52,983 shares worth $23.63 million, representing 38.56% of the fund's assets. The concentrated bet reflects confidence in CyberArk's strong growth metrics, including 45% year-over-year ARR growth to $1.34 billion and 57% subscription ARR growth, with the company's position further supported by Palo Alto Networks' proposed $25 billion acquisition.

CYBR - Strong financial performance with 45% YoY ARR growth to $1.34B, 57% subscription ARR growth, expanding non-GAAP operating margins to 19%, record quarterly net new ARR of $68M, and a major institutional investor increasing exposure to 39% of portfolio. Additionally supported by Palo Alto Networks' $25B acquisition proposal.

#identity security #privileged access management #ARR growth #subscription revenue #concentrated portfolio #acquisition #enterprise security

G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider

GlobeNewswire Inc. • Sns Insider

G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - SNS Insider

01/05/2026 10:00 AM • The global GPCRs market is projected to grow from USD 3.92 billion in 2024 to USD 6.04 billion by 2032 at a CAGR of 5.59%, driven by rising drug discovery activities, expanding applications in targeted therapeutics, and increasing prevalence of chronic and neurological disorders. The U.S. market is expected to reach USD 1.66 billion by 2032. North America dominates with 37.10% market share, while Asia Pacific shows the fastest growth at 6.12% CAGR. Cell lines and cancer research lead their respective segments.

NVO - Announced a strategic USD 2.2 billion partnership with Septerna in May 2025 to develop GPCR-targeted oral small-molecule medicines for obesity and cardiometabolic disorders, demonstrating significant investment and confidence in GPCR-based drug development.

#GPCRs market #drug discovery #targeted therapeutics #pharmaceutical research #cancer research #CNS research #precision medicine #cell lines #detection kits #cAMP functional assays

Hydrofluoroether Market Projected to Reach US$ 383.11 Million by 2035 | Astute Analytica

GlobeNewswire Inc. • Astute Analytica

Hydrofluoroether Market Projected to Reach US$ 383.11 Million by 2035 | Astute Analytica

01/05/2026 10:00 AM • The hydrofluoroether (HFE) market is experiencing a critical supply shortage following 3M's strategic exit from PFAS manufacturing by end of 2025. The market is projected to grow from USD 172.60 million in 2025 to USD 383.11 million by 2035 at a CAGR of 8.3%. Despite a 15-20% undersupply in high-purity grades, demand remains inelastic due to semiconductor manufacturing and AI-driven data center cooling requirements. Competitors like AGC and Tianhe are rapidly filling the void with drop-in replacements, while pricing mechanisms are shifting toward index-linked contracts with 12-15% premiums over 2023 rates.

MMM - 3M's complete withdrawal from PFAS manufacturing has created a massive supply vacuum in the HFE market, removing a dominant volume leader and destabilizing the industry's established pricing and supply structures.

#hydrofluoroether market #supply shock #3M exit #semiconductor manufacturing #immersion cooling #AI data centers #PFAS manufacturing #pricing volatility #supply chain consolidation

Limitless X Appoints Seasoned Consumer Products and Manufacturing Executive Daniel Sanders as President

GlobeNewswire Inc. • Na

Limitless X Appoints Seasoned Consumer Products and Manufacturing Executive Daniel Sanders as President

01/05/2026 10:00 AM • Limitless X Holdings Inc. (OTCQX: LIMX) appointed Daniel Sanders as President, effective immediately. Sanders brings over 20 years of experience in consumer nutraceuticals, manufacturing, and retail distribution across major retailers including Walmart, Costco, and Whole Foods. The appointment aims to strengthen the company's manufacturing strategy, supply chain execution, and national retail expansion efforts.

LIMX - The appointment of an experienced executive with 20+ years in manufacturing and retail distribution is expected to strengthen operational efficiency, accelerate retail placements, and drive revenue growth. Management expresses confidence in Sanders' ability to unlock significant growth opportunities and create long-term shareholder value through disciplined execution and retail expansion.

#executive appointment #manufacturing #retail distribution #supply chain #consumer products #nutraceuticals #business expansion